SYNTHESIS Welcomes New Editorial Board Member Professor Chris Vanderwal
We are thrilled to announce that Professor Chris Vanderwal from the University of California, Irvine, USA, has joined the SYNTHESIS Editorial Board as Associate Editor with effect of January 1st, 2025.
Chris Vanderwal received a B.Sc. degree in Biochemistry (1995) and an M.Sc. degree in Chemistry (1998) from the University of Ottawa. He then moved to the Scripps Research Institute for doctoral studies in the group of Professor Erik Sorensen. After obtaining his Ph.D. in 2003, Chris joined the group of Professor Eric Jacobsen at Harvard University as a Jane Coffin Childs postdoctoral associate. In 2005, Chris began his independent academic career at the University of California, Irvine. In 2011, Chris was promoted with tenure to Associate Professor and was named a UCI Chancellor’s Faculty Fellow, and in 2013, he was promoted to Professor of Chemistry, and he was recently appointed Professor of Pharmaceutical Sciences.
Chris’s group focuses on the synthesis of complex natural products, including alkaloids, terpenoids, and polyhalogenated secondary metabolites. They develop target-specific but potentially broadly applicable methods en route to the natural product goals, and frequently engage in post-synthesis collaborative experiments to investigate biological activity of the target and synthetic analogues.
Detailed Profile & Publications
We welcome Professor Chris Vanderwal on the SYNTHESIS Editorial Board and look forward to a successful and inspiring collaboration with him!
Take advantage of this opportunity to have your work reviewed by our esteemed new Associate Editor — submit your papers today!
About SYNTHESIS
SYNTHESIS is an international full-paper journal devoted to the advancement of the science of chemical synthesis. It covers all fields of organic chemistry involving synthesis, including catalysis, organometallic, medicinal, biological, and photochemistry, but also related disciplines.
